These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 9843182

  • 21. Recombinant albumins containing additional peptide sequences smaller than barbourin retain the ability of barbourin-albumin to inhibit platelet aggregation.
    Sheffield WP, Wilson B, Eltringham-Smith LJ, Gataiance S, Bhakta V.
    Thromb Haemost; 2005 May; 93(5):914-21. PubMed ID: 15886809
    [Abstract] [Full Text] [Related]

  • 22. Differences in binding of (99m)Tc-disintegrins to integrin alphavbeta3 on tumor and vascular cells.
    Knight LC, Romano JE, Cosenza SC, Iqbal NM, Marcinkiewicz C.
    Nucl Med Biol; 2007 May; 34(4):371-81. PubMed ID: 17499726
    [Abstract] [Full Text] [Related]

  • 23. Measurement of glycoprotein IIb/IIIa blockade by flow cytometry with fluorescein isothiocyanate-conjugated crotavirin, a member of disintegrins.
    Liu CZ, Hur BT, Huang TF.
    Thromb Haemost; 1996 Oct; 76(4):585-91. PubMed ID: 8903000
    [Abstract] [Full Text] [Related]

  • 24. Characterization of the cross-linking site of disintegrins albolabrin, bitistatin, echistatin, and eristostatin on isolated human platelet integrin GPIIb/IIIa.
    Calvete JJ, McLane MA, Stewart GJ, Niewiarowski S.
    Biochem Biophys Res Commun; 1994 Jul 15; 202(1):135-40. PubMed ID: 8037704
    [Abstract] [Full Text] [Related]

  • 25. [Disintegrins: potent inhibitors of platelet aggregation].
    Perutelli P.
    Recenti Prog Med; 1995 Apr 15; 86(4):168-74. PubMed ID: 7617961
    [Abstract] [Full Text] [Related]

  • 26. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
    Bednar RA, Gaul SL, Hamill TG, Egbertson MS, Shafer JA, Hartman GD, Gould RJ, Bednar B.
    J Pharmacol Exp Ther; 1998 Jun 15; 285(3):1317-26. PubMed ID: 9618439
    [Abstract] [Full Text] [Related]

  • 27. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
    Aoki T, Tomiyama Y, Honda S, Senzaki K, Tanaka A, Okubo M, Takahashi F, Takasugi H, Seki J.
    Thromb Haemost; 1998 Jun 15; 79(6):1184-90. PubMed ID: 9657446
    [Abstract] [Full Text] [Related]

  • 28. Thrombus imaging in a primate model with antibodies specific for an external membrane protein of activated platelets.
    Palabrica TM, Furie BC, Konstam MA, Aronovitz MJ, Connolly R, Brockway BA, Ramberg KL, Furie B.
    Proc Natl Acad Sci U S A; 1989 Feb 15; 86(3):1036-40. PubMed ID: 2521733
    [Abstract] [Full Text] [Related]

  • 29. Disintegrin interaction with alpha V beta 3 integrin on human umbilical vein endothelial cells: expression of ligand-induced binding site on beta 3 subunit.
    Juliano D, Wang Y, Marcinkiewicz C, Rosenthal LA, Stewart GJ, Niewiarowski S.
    Exp Cell Res; 1996 May 25; 225(1):132-42. PubMed ID: 8635506
    [Abstract] [Full Text] [Related]

  • 30. A comparison of the effect of decorsin and two disintegrins, albolabrin and eristostatin, on platelet function.
    McLane MA, Gabbeta J, Rao AK, Beviglia L, Lazarus RA, Niewiarowski S.
    Thromb Haemost; 1995 Nov 25; 74(5):1316-22. PubMed ID: 8607116
    [Abstract] [Full Text] [Related]

  • 31. Augmentation of inhibitory effects of glycoprotein IIb-IIIa antagonists in patients with diabetes.
    Keating FK, Whitaker DA, Sobel BE, Schneider DJ.
    Thromb Res; 2004 Nov 25; 113(1):27-34. PubMed ID: 15081562
    [Abstract] [Full Text] [Related]

  • 32. Blockade of glycoprotein IIb/IIIa by crotavirin, a member of disintegrins, prevents platelet from activation and aggregation by Staphylococcus aureus bacteria.
    Liu CZ, Huang HY, Tsai PJ, Shih MH.
    Thromb Res; 2005 Nov 25; 116(2):145-55. PubMed ID: 15907530
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of 64Cu- and 125I-radiolabeled bitistatin as potential agents for targeting alpha v beta 3 integrins in tumor angiogenesis.
    McQuade P, Knight LC, Welch MJ.
    Bioconjug Chem; 2004 Nov 25; 15(5):988-96. PubMed ID: 15366951
    [Abstract] [Full Text] [Related]

  • 34.
    Leung K.
    ; 2004 Nov 25. PubMed ID: 20641217
    [Abstract] [Full Text] [Related]

  • 35. Structural analysis of the KGD sequence loop of barbourin, an alphaIIbbeta3-specific disintegrin.
    Minoux H, Chipot C, Brown D, Maigret B.
    J Comput Aided Mol Des; 2000 May 25; 14(4):317-27. PubMed ID: 10815769
    [Abstract] [Full Text] [Related]

  • 36. Thrombus formation with rehydrated, lyophilized platelets.
    Fischer TH, Merricks EP, Bode AP, Bellinger DA, Russell K, Reddick R, Sanders WE, Nichols TC, Read MS.
    Hematology; 2002 Dec 25; 7(6):359-69. PubMed ID: 12475741
    [Abstract] [Full Text] [Related]

  • 37. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease.
    Kaplan R, Gabbeta J, Sun L, Mao GF, Rao AK.
    Br J Haematol; 2000 Dec 25; 111(3):954-64. PubMed ID: 11122160
    [Abstract] [Full Text] [Related]

  • 38. Convulxin induces platelet activation by a tyrosine-kinase-dependent pathway and stimulates tyrosine phosphorylation of platelet proteins, including PLC gamma 2, independently of integrin alpha IIb beta 3.
    Francischetti IM, Ghazaleh FA, Reis RA, Carlini CR, Guimarães JA.
    Arch Biochem Biophys; 1998 May 15; 353(2):239-50. PubMed ID: 9606958
    [Abstract] [Full Text] [Related]

  • 39. Disposition of L-738,167, a potent and long-acting fibrinogen receptor antagonist, in dogs. Dose-dependent pharmacokinetics.
    Prueksaritanont T, Gorham LM, Naue JA, Hamill TG, Askew BC, Vyas KP.
    Drug Metab Dispos; 1997 Mar 15; 25(3):355-61. PubMed ID: 9172954
    [Abstract] [Full Text] [Related]

  • 40. Platelet alpha IIb beta 3: a pharmacological integrin as a target to design new molecules with antithrombotic activity.
    Marguerie G, Jarrin A, Andrieux A.
    Nouv Rev Fr Hematol (1978); 1993 Jun 15; 35(3):253-4. PubMed ID: 7687771
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.